IgAN
American Society of Nephrology (ASN) 2024
San Diego, CA
October 23-27, 2024
Abstracts and Posters
ORIGIN 3: Pivotal Ph3 Study Evaluating Effect of Atacicept vs. Placebo on Proteinuria and Kidney Function Preservation in IgAN
Lafayette R, et al.
ORIGIN Extend: A Rollover Extension Study to Continue to Evaluate the Long-Term Safety and Efficacy of Atacicept
Lafayette R, et al.
Abstract and Oral Presentation
Long-Term Results From the ORIGIN Phase 2b Study of Atacicept for the Treatment of IgAN
Barratt J, et al.